Contact: Colleen T. White
Patricia A. Spinella
Franklin Lakes, NJ (October 07, 2009) --
BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced that it is pleased to have been ranked in the top 100 companies in Newsweek’s inaugural “Green Rankings” of the 500 largest U.S. corporations based on environmental performance, policies and reputation. BD placed third in the Healthcare sector and 83rd overall.
Additionally, BD has been selected as a component of the Dow Jones Sustainability World Index (DJSI World) and the DJSI North America Index for the fourth and fifth consecutive years, respectively. Dow Jones Sustainability Index assessments examine corporate economic, environmental and social performance, with a strong focus on long-term shareholder value. Inclusion in the DJSI World puts BD in the top 10 percent of companies in the healthcare sector assessed for sustainability leadership.
“BD strongly believes in balancing the triple bottom line – achieving strong economic performance, promoting environmental stewardship and advancing social responsibility,” said Edward J. Ludwig, BD Chairman and Chief Executive Officer. “We are making very good progress, and there is much more to be done.”
Newsweek collaborated with TruCost (which calculated each companies Environmental Impact Score), KLD Research & Analytics (which created the Green Policies Score) and CorporateRegister.com, which conducted a reputation survey of CEOs, environmental officers and academics. To view the full list, please visit www.newsweek.com/green.
Launched in 1999, the Dow Jones Sustainability Indexes are the first global indexes tracking the financial performance of the leading sustainability-driven companies worldwide. To learn more, please visit www.sustainability-index.com.
BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. The Company’s capabilities are instrumental in combating many of the world’s most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 28,000 people in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. For more information, please visit www.bd.com.